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The P2Y2 receptor is a uridine/adenosine triphosphate (UTP/
ATP)-sensitive G-protein-linked nucleotide receptor that previ-
ously has been reported to stimulate the phosphoinositide
signaling pathway. Messenger RNA for this receptor has been
detected in brain tissue. We have investigated the coupling of
the molecularly deﬁned rat P2Y2 receptor to neuronal N-type
Ca
21 channels and to M-type K
1 channels by heterologous
expression in rat superior cervical sympathetic (SCG) neurons.
After the injection of P2Y2 cRNA, UTP inhibited the currents
carried by both types of ion channel. As previously reported
[Filippov AK, Webb TE, Barnard EA, Brown DA (1997) Inhibition
by heterologously expressed P2Y2 nucleotide receptors of
N-type calcium currents in rat sympathetic neurones. Br J
Pharmacol 121:849–851], UTP inhibited the Ca
21 current
(ICa(N)) by up to 64%, with an IC50 of ;0.5 mM. We now ﬁnd that
UTP also inhibited the K
1
M current (IK(M)) by up to 61%, with an
IC50 of ;1.5 mM. UTP had no effect on either current in neurons
not injected with P2Y2 cRNA. Structure–activity relations for the
inhibition of ICa(N) and IK(M) in P2Y2 cRNA-injected neurons were
similar, with UTP $ ATP . ITP . . GTP,UDP. However, coupling
to these two channels involved different G-proteins: pretreat-
ment with Pertussis toxin (PTX) did not affect UTP-induced
inhibition of IK(M) but reduced inhibition of ICa(N) by ;60% and
abolished the voltage-dependent component of this inhibition.
In unclamped neurons, UTP greatly facilitated depolarization-
induced action potential discharges. Thus, the single P2Y2





M channels with near-equal facility. This implies
that the P2Y2 receptor may induce a broad range of effector
responses in the nervous system.
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Nucleotides such as ATP play a signiﬁcant neurotransmitter role
in the mammalian nervous system (Burnstock, 1972, 1990; Ed-
wards and Gibb, 1993; Zimmermann, 1994). There are two fam-
ilies of target nucleotide receptors known at the molecular
level—ligand-gated P2X receptors and G-protein-coupled P2Y
receptors (North and Barnard, 1997).
The P2Y2 receptor is a member of the family of P2Y
G-protein-coupled receptors and is sensitive to both ATP and
UTP; it was cloned originally from mouse NG108-15 neuroblas-
toma X glioma hybrid cells (Lustig et al., 1993). In common with
other P2Y receptors (Boarder et al., 1995), P2Y2 receptors from
different species all couple to the enzyme phospholipase C (PLC),
thereby increasing inositol phosphate production and elevating
intracellular [Ca
21] (Erb et al., 1993; Lustig et al., 1993; Parr et
al., 1994; Rice et al., 1995; Chen et al., 1996; Nicholas et al., 1996).
Messenger RNA for the P2Y2 receptor, which is found in a
range of tissues, is also present in the brain (Lustig et al., 1993),
so the question arises as to what effect the activation of this
receptor might have on neural function. In native NG108-15 cells,
UTP inhibits two membrane ionic currents—an M-like K
1 cur-
rent (“M-current”) and the voltage-gated Ca
21 current (Filippov
et al., 1994; Filippov and Brown, 1996). The former was to be
expected because other receptors that activate PLC inhibit
M-currents (Brown, 1988), but Ca
21 current inhibition was un-
expected, especially because it was mediated (in part, at least) by
a different G-protein from that responsible for M-current inhibi-
tion (Filippov and Brown, 1996). This raised the question
whether both effects actually were produced by the same receptor
as that previously cloned from these cells or whether two different
receptors were responsible. If the former, was this a peculiarity of
this particular cell line, or would it also hold for primary neurons?
To address these questions, we have expressed the recombinant
rat P2Y2 receptor in primary cultured rat superior cervical sym-
pathetic (SCG) neurons by microinjecting cRNA, in the manner
used by Ikeda et al. (1995) to express heterologous “metabo-
tropic” glutamate receptors, and then recording the effects of
activating these exogenous receptors with UTP on the N-type
Ca
21 currents (ICa(N); Hirning et al., 1988; Plummer et al., 1989;
Regan et al., 1991) and M-type K
1 currents (IK(M); Constanti
and Brown, 1981) that are present in these neurons. In prelimi-
nary experiments (Filippov et al., 1997) we found that the acti-
vation of these expressed receptors did indeed inhibit ICa(N).I n
the present experiments we have analyzed this action in more
detail and have gone on to test whether the same single receptor
also can inhibit the M-type K
1 current. We ﬁnd that it can; the
two currents are inhibited by UTP with near-equal potencies and
efﬁcacy, although mediated mainly by different G-proteins, and in
joint response increase the excitability of these neurons. Thus, the
P2Y2 receptor appears to be unusually promiscuous in terms of its
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This has interesting implications for its potential function in
nerve cells.
MATERIALS AND METHODS
cRNA preparation. The rat P2Y2 receptor cDNA was obtained from Dr.
Zeng-Ping Chen (Department of Neuroscience and Cell Biology, Uni-
versity of Medicine and Dentistry of New Jersey, Robert Wood Johnson
Medical School, Piscataway, NJ).A2k bEcoRI–XhoI fragment was
cloned into the reciprocal sites of pBK/CMV. The wild-type green
ﬂuorescent protein (GFP) cDNA, in pBluescript, also was used. Super-
coiled plasmid DNA was prepared from both constructs and linearized
with XhoI for P2Y2 and with EcoRI for GFP before use as a template for
cRNA synthesis. Capped cRNA was transcribed with T3 polymerase
(Message Machine, Ambion, Austin, TX), and an aliquot of each was
analyzed on a denaturing agarose gel to check its integrity before
polyadenylation, using poly(A
1) polymerase (Sigma, St. Louis, MO)
according to the manufacturer’s recommendations. After extractions in
turn with phenol, phenol/chloroform, and chloroform and isopropanol
precipitation, the cRNA was stored as an ethanol precipitate at 270°C
before use.
Neuron preparation and cRNA injection. Single SCG neurons were
dissociated from rats aged 15–19 d, and plated on poly-D-lysine-coated
glass coverslips bordered by 2 cm plastic rings as previously described
(Marrion et al., 1987). At 4 hr after plating, the neurons were microin-
jected with an equal mixture of cRNA for the P2Y2 receptor (ﬁnal
pipette concentration of 0.5 or 1.25 mg/ml dissolved in water) and cRNA
for GFP (used as a marker for foreign cRNA expression; Marshall et al.,
1995) or, for controls, with GFP cRNA alone. cRNA solution (1.2 ml) was
loaded into prepulled high-resistance (;30 MV) Pyrex glass pipettes and
injected manually into single neurons by the application of gentle pres-
sure to the back of the pipette with a syringe as described previously for
injection of antisera (Caulﬁeld et al., 1994). Successful injection usually
resulted in a ;10% increase in cell volume (Ikeda et al., 1995). After
injections, cells were incubated for 14–24 hr in a humidiﬁed incubator
(5% CO2/95% O2) at 37°C. Injected neurons that successfully expressed
cRNA were identiﬁed as bright ﬂuorescent cells, using an inverted
microscope (Diaphot 200, Nikon, Tokyo, Japan) equipped with an epi-
ﬂuorescent N B2E block (Nikon). When required, Pertussis toxin (PTX)
at a ﬁnal concentration of 500 ng/ml was added to the culture media 1–2
hr after neuron injection. Electrophysiological recordings were made
14–24 hr after injection at room temperature (20°C). Some experiments
on neuron excitability were made at 34°C.
Ca
21 channel current recording. Currents through voltage-gated Ca
21
channels were recorded by the conventional whole-cell patch-clamp
method as described previously (Caulﬁeld et al., 1994). Cells were
superfused (20–25 ml/min) with a solution consisting of (in mM) 120
tetraethylammonium chloride, 3 KCl, 1.5 MgCl2, 5 BaCl2 (or 5 CaCl2),
10 HEPES, and 11.1 glucose plus 0.5 mM tetrodotoxin. The pH was
adjusted to 7.35 with NaOH. Patch electrodes (2–3 MV) were ﬁlled with
a solution containing (in mM)1 1 0Cs Cl ,3M gCl 2, 40 HEPES, 3 EGTA,
2N a 2ATP, and 0.5 Na2GTP (pH-adjusted to 7.4 with CsOH). Neurons
were voltage-clamped with a discontinuous (“switching”) ampliﬁer (Ax-
oclamp 2B) with a sampling voltage at 6–8 kHz (50% duty cycle).
Commands were generated via a Digidata 1200 interface, using pClamp
6 computer software (Axon Instruments, Foster City, CA). Ca
21 channel
currents were evoked routinely every 20 sec with a 100 msec depolarizing
rectangular test pulse to 0 mV from a holding potential of 290 mV. To
obtain current–voltage (I–V) relations, we evoked currents by test pulses
in 10 mV increments to 140 mV, starting from the holding potential of
290 mV. Where required, I–V relations were obtained by using 750 msec
ramp depolarizations from 290 to 1 40 mV (see Docherty et al., 1991).
Currents were digitized and stored on a computer for later analysis by
pClamp 6 software (Axon Instruments). Ca
21 channel current ampli-
tudes were measured isochronally 10 msec from the onset of the rectan-
gular test pulse (Ikeda et al., 1995), i.e., near to the peak of the control




21 in the external solution at the end of each experiment to block all
Ca
21 channel currents, and we digitally subtracted the residual current




1 current recordings. Whole-cell M-currents (IK(M)) were
recorded by the perforated patch-clamp method (Horn and Marty, 1988),
as described for the application to SCG neurons by Caulﬁeld et al.
(1994). Brieﬂy, patch pipettes (2–4 MV) were ﬁlled by dipping the tip
into a ﬁltered solution containing (in mM) 90 potassium acetate, 20 KCl,
3 MgCl2, 40 HEPES, and 0.1 BAPTA (pH-adjusted to 7.4 by KOH) for
20–60 sec. Then the pipette was back-ﬁlled with the same solution
containing 0.125 mg/ml amphotericin B as the permeabilizing agent (Rae
et al., 1991). Access resistance after permeabilization was 8–15 MV.
Neurons were superfused (20–25 ml/min) with external modiﬁed Krebs’
solution containing (in mM) 120 NaCl, 3 KCl, 1.5 MgCl2,2.5CaCl2,1 0
HEPES, and 11.1 glucose (pH-adjusted to 7.3 with NaOH). Neurons
were voltage-clamped at 220 or 230 mV with a switching ampliﬁer, and
M-currents were deactivated with 1 sec hyperpolarizing steps at 5 sec
intervals. I–V relationships were obtained by using incremental voltage
steps of 10 mV between 210 and 2100 mV; currents were measured at
the end of each hyperpolarizing step. For dose–response curves, currents
were measured at 230 mV from steady-state I–V relations obtained by
using a ramp voltage command of 20 sec from 220 to 290 mV. The leak
component of current was estimated in both cases by extrapolating a
linear ﬁt to the I–V relationship from the negative potential region, where
only ohmic currents were observed. All commands, current recordings,
and analyses were made with Digidata 1200 interface and pClamp 6
software (Axon Instruments).
Statistical analysis. Data are presented as mean 6 SEM as appropriate.
Student’s t test (unpaired) was applied to determine statistical signiﬁ-
cance. The difference was considered signiﬁcant if p # 0.05. Dose–
response curves were determined by using concentrations that were
added cumulatively, with 1 min exposure times. Curves were ﬁt (using
Origin 4.1 software) to pooled data points to the Hill equation: y 5
ymax z x
n H/(x
n H 1 K
n H), where y 5 the observed percentage of inhibition,
ymax 5 extrapolated maximal percentage of inhibition, x 5 nucleotide
concentration (mM), K 5 IC50 (mM), and nH 5 the Hill coefﬁcient.
Chemicals. UTP rather than ATP was used as the main agonist
throughout to preclude the activation of ATP-sensitive endogenous P2X
ligand-gated channels (Cloues et al., 1993). Drugs were applied to the
external solution by bath perfusion (bath exchange rate #5 sec). Tetro-
dotoxin was obtained from Calbiochem (La Jolla, CA); uridine 59-
triphosphate (UTP) was from Pharmacia Biotech (Uppsala, Sweden) and
from Sigma; ATP, inosine 59-triphosphate (ITP), guanosine 59-
triphosphate (GTP), acetylcholine chloride, (2)-norepinephrine bitar-
trate, nifedipine, BAPTA, and amphotericin B were all from Sigma;
adenosine 59-diphosphate (ADP) and uridine 59-diphosphate (UDP)
were from Sigma and Boehringer Mannheim GmbH (Mannheim, Ger-
many); hexokinase was from Boehringer Mannheim GmbH;
oxotremorine-M (OxoM) was from Research Biochemicals (Natick,
MA); Pertussis toxin (PTX) was from Porton Products (Dorset, UK);
CdCl2 (AnalaR grade) was from BDH Chemicals (Poole, UK); BaCl2
and CsCl were from Aldrich (Milwaukee, WI). Nifedipine was prepared




21 channel current inhibition
We have reported previously that, in SCG neurons preinjected
with 1.25 mg/ml P2Y2 cRNA (together with GFP cRNA), the
application of UTP produced a reversible inhibition of the Ca
21
channel current by up to 64.0 6 0.8%, with an IC50 of 0.50 6 0.03
mM and that, at 0.5 mg/ml P2Y2 cRNA, UTP inhibited the current
by up to 50.2 6 0.6%, with an IC50 0.90 6 0.05 mM (Filippov et al.,
1997). Because no signiﬁcant inhibition was detected on applying
100 mM UTP to neurons injected with GFP cRNA alone, this
effect could be attributed entirely to the activation of newly
expressed P2Y2 receptors and not to the activation of any endog-




21 current inhibition in SCG neurons produced by activation
of some endogenous receptors (see Hille, 1994) or by heterolo-
gously expressed mGluR2 receptors (Ikeda et al., 1995) is
voltage-dependent—that is, it is reduced at depolarized com-
mands (or by predepolarization; Grassi and Lux, 1989) and is
accompanied by “kinetic slowing” resulting from time-dependent
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Figure 1 shows that the block produced by activating heterologously
expressed P2Y2 receptors shares this property. Thus, current–
voltage curves constructed by using either stepped (Fig. 1A,B)o r
ramped (Fig. 1C) commands showed a greater inhibition by UTP at
negative potentials than at positive potentials (resulting in a positive
shift of the current peak). For example, in Figure 1A peak current
inhibition was reduced from ;6 3 %a t0m Vt o;26% at 140 mV.
Also, as shown in Figure 1, B and D, current activation was slowed
in the presence of UTP, such that inhibition was less at the end of the
40 msec command than at the beginning. Finally, inhibition was
reduced (from 65.0 6 3.1 to 24.9 6 5.4%) and the slowing of current
activation was abolished when the test command was preceded by a
20 msec depolarizing prepulse to 1120 mV (Fig. 1D). Such effects
have been interpreted to indicate that the activated G-protein (prob-
ably the bg-subunit; Herlitze et al., 1996; Ikeda, 1996; Delmas et al.,
1998a,b) interacts directly with the Ca
21 channel protein to induce
a gating shift (Dolphin, 1995; Jones and Elmslie, 1997).
Pertussis toxin distinguishes two pathways for P2Y2-mediated
Ca
21 channel current inhibition
Voltage-dependent Ca
21 current inhibition of the type illustrated
in Figure 1 is usually (although not invariably; Ehrlich and
Elmslie, 1995) associated with activation by the receptor of a
G-protein of the Pertussis toxin-sensitive Gi/Go family (Hille,
1994). We tested whether this applied to expressed P2Y2 recep-
tors by overnight incubation of injected neurons with 0.5 mg/ml
Pertussis toxin (PTX). In cells preinjected with 1.25 mg/ml P2Y2
cRNA, PTX substantially (;61%) but incompletely reduced the
inhibition produced by 10 mM UTP (Fig. 2A). In contrast, in the
same neurons the inhibition produced by 10 mM norepinephrine
(which is mediated primarily by Go; Caulﬁeld et al., 1994; Del-
Figure 1. Voltage-dependent inhibition of Ca
21 channel currents by UTP in rat SCG neurons expressing heterologous P2Y2 receptors. Neurons were
preinjected with 1.25 mg/ml P2Y2 cRNA. Records show leak-subtracted Ca
21 channel currents recorded at room temperature (20°C), using the
whole-cell (ruptured patch) variant of the patch-clamp technique with 5 mM Ba
21 as the charge carrier (IBa; see Materials and Methods). A, IBa amplitude
plotted against membrane voltage (I–V relationship) in the absence ( ﬁlled circles) and presence ( ﬁlled squares)o f1 0 0mM UTP. Currents were evoked
by 10 mV incrementing test pulses, starting from a holding potential of 290 to 140 mV; amplitudes were measured 10 msec from the onset of the test
pulse. B, Superimposed currents from A at 0 and 140 mV test potentials in the absence and presence of UTP. Note that the inhibition is less at 140
than at 0 mV. C, Superimposed currents recorded with 750 msec depolarizing voltage ramps from 290 to 1 40 mV (see Materials and Methods) in the
absence and presence of 100 mM UTP. Note that the inhibition is less at more positive voltages. D, Superimposed currents (lower traces) recorded with
a double-pulse voltage protocol (upper traces) in the absence and presence of 100 mM UTP. The current was recorded ﬁrst with a 40 msec test pulse to
0 mV; then, after a 2 sec interval, a 25 msec conditioning prepulse to 1120 mV was applied, followed 4 msec later by a second 40 msec test pulse to 0
mV. The bar chart at the bottom shows the mean percentage of current inhibition (measured after 10 msec at 0 mV command potential) by 100 mM UTP
before (Prep.0) and after (Prep.120) the 1120 mV prepulse. Error bars show SEM; n 5 number of cells. Note that the inhibition is much less after the
prepulse. Note also that the prepulse abolished the slowing of the current onset at 0 mV produced by UTP.
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(Beech et al., 1992; Chen and Schoﬁeld, 1993; Caulﬁeld et al.,
1994; Delmas et al., 1998a), thus indicating the effectiveness of
the PTX treatment. Nevertheless, because the initial inhibition
produced by UTP exceeded that produced by norepinephrine, we
were concerned that the substantial component of PTX-resistant
inhibition might have resulted from overexpression (and aberrant
coupling) of the P2Y2 receptors. This appeared not to be the case,
because PTX produced a comparable degree of attenuation
(254%) of the response to UTP in cells preinjected with 0.5
mg/ml P2Y2 cRNA, although the initial inhibition produced by
UTP (41.6 6 5.5%) was now less than that produced by norepi-
nephrine (46.1 6 4.2%; Fig. 2D).
In contrast to the partial antagonism of overall inhibition, PTX
pretreatment virtually eliminated the voltage dependence of
P2Y2-mediated inhibition; the characteristic slowing of current
activation by UTP (compare with Fig. 1) was no longer apparent
after PTX treatment (Fig. 3A), and the 1120 mV depolarizing
prepulse did not reverse the inhibition signiﬁcantly (Fig. 3B,C).
Thus, the PTX-insensitive component of block also appeared to
be voltage-insensitive.
One possible explanation for the PTX-resistant voltage-
insensitive component of inhibition is that it reﬂects the inhibition
of an L-type current, rather than the N-type current (Hille, 1994).
This possibility is enhanced by previous observations that UTP
inhibits both L-type and N-type currents in NG108-15 cells
(Filippov and Brown, 1996). To check this, we tested the effect of
2–10 mM nifedipine on the response to UTP of PTX-pretreated
SCG neurons preinjected with 1.25 mg/ml P2Y2 cRNA. In agree-
ment with previous observations on non-PTX-treated cells (Fil-
ippov et al., 1997), nifedipine itself did not produce any signiﬁcant
inhibition of the current (22.5 6 1.7%; n 5 13), nor did it affect
the inhibitory action of UTP (2nifedipine, 229.4 6 3.5%; 1ni-
fedipine, 227.3 6 4.25%; n 5 6). Thus, the residual PTX-
insensitive block is not attributable to the inhibition of L-type
channels.
Coupling of P2Y2 receptors to M-type K
1 currents
M-currents are sustained voltage-gated K
1 currents that are
activated when SCG neurons are depolarized above 270 mV
(Constanti and Brown, 1981) (for review, see Brown, 1988). They
can be inhibited by activating endogenous M1-muscarinic acetyl-
choline receptors (Marrion et al., 1989; Bernheim et al., 1992),
angiotensin receptors (Shapiro et al., 1994), or bradykinin recep-
tors (Jones et al., 1995)—in all cases via PTX-insensitive
G-proteins (probably Gq; see Caulﬁeld et al., 1994; Jones et al.,
1995).
There is some evidence for the presence of endogenous P2Y
receptors in intact SCGs [Connolly et al. (1993); Boehm et al.
(1995) and personal communication; Connolly and Harrison
(1995); Von Kugelgen et al. (1997)]. However, we found that UTP
did not affect the M-current signiﬁcantly in the uninjected disso-
ciated neurons that we have used, although some other nucleo-
tides did (see below and Fig. 7A). We therefore have tested
whether the activation of heterologously expressed P2Y2 recep-
tors inhibits the M-current in these neurons, and, if so, how this
compares with inhibition of Ca
21 current.
Figure 4 illustrates the effect of UTP on M-currents in cells
preinjected with 1.25 mg/ml P2Y2 cRNA. The cell was predepo-
larized to 220 mV to preactivate the M-current and then hyper-
polarized in steps of 210 mV for 1 sec each to deactivate the
current; deactivation is signaled by the inward tail currents, which
reverse at EK (approximately 290 mV). UTP (10 mM) clearly
inhibited the M-current; this is indicated by (1) the inward shift in
holding current at 220 mV (reﬂecting the reduction in outward
K
1 current), (2) reduced current responses to depolarizing steps
(reduced conductance) and the loss of M-current deactivation
tails, and (3) reduced outward rectiﬁcation in the current–voltage
curve positive to 270 mV, with no change in slope negative to
270 mV (indicating no change in “leak” current).
M-current inhibition was quantitated by using voltage ramps to
obtain current–voltage curves (see Fig. 6) and then subtracting
from the total outward current at 230 mV the extrapolated linear
leak currents from potentials negative to 270 mV. UTP (10 mM)
inhibited the M-current by 60.8 6 9.6% (n 5 8) in neurons
preinjected with 1.25 mg/ml P2Y2 cRNA. As noted above, UTP
had no signiﬁcant effect at 100 mM (0.6 6 0.4% inhibition) in ﬁve
noninjected cells (Fig. 5A). In four of these same cells the acti-
vation of the endogenous muscarinic acetylcholine receptors with
10 mM oxotremorine-M (OxoM) inhibited the current by 55.4 6
11.4%, in accordance with previous observations (see Caulﬁeld et
al., 1994), indicating that the endogenous transduction machinery
was intact.
With the use of increasing concentrations of UTP, mean IC50
values and extrapolated maximum inhibitions were 1.49 6 0.18
mM and 48.0 6 1.2%, respectively, after 1.25 mg/ml P2Y2 cRNA
was injected, and 2.41 6 0.43 mM and 43.2 6 1.9% after 0.5 mg/ml
P2Y2 cRNA was injected (Fig. 6). These IC50 values are approx-
imately three times higher than those determined for N-type
Ca
21 current inhibition (Filippov et al., 1997) (superimposed
curves in Fig. 6). The lower apparent maximum inhibition with
increasing UTP concentrations than those in Figure 5 may reﬂect
some degree of desensitization (apparent as a slow partial recov-
ery of M-current during prolonged application of UTP); the
extent to which this affected IC50 estimates is unclear.
In contrast to its effect on Ca
21 current inhibition, PTX
produced no signiﬁcant attenuation of UTP-induced M-current
inhibition (Fig. 5B). Also, inhibition of M-current showed no
Figure 2. Pertussis toxin (PTX) distinguishes two pathways for P2Y2-
mediated Ca
21 channel current inhibition. The bar charts show the mean
inhibition of IBa amplitude by 10 mM UTP and by 10 mM norepinephrine
in neurons pretreated with PTX (0.5 mg/ml, overnight; 1PTX) and in
PTX-untreated neurons (Control). Error bars show SEM; n 5 number of
cells. Neurons were injected with 1.25 mg/ml P2Y2 cRNA (A)o r0 . 5mg/ml
P2Y2 cRNA (B). Currents were recorded by stepping for 100 msec from
290 to 0 mV and measured 10 msec from the onset of the test pulse. Note
that PTX pretreatment completely prevented the effect of norepineph-
rine, but not that of UTP.
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curve nor the kinetics of the deactivation relaxations was altered
appreciably in the presence of UTP.
We further tested the effects of several other nucleotides, using
a standard concentration of 10 mM (Fig. 7A). The approximate
order of activity was UTP $ ATP . ITP . . GTP,UDP. This
accords with their relative activities in inhibiting the Ca
21 cur-
rent in P2Y2-expressing SCG neurons (Fig. 7B) (see Filippov et
al., 1997) and also with stimulation of inositol phosphate produc-
tion or intracellular Ca
21 elevation in other cells expressing
cloned P2Y2 receptors (Lustig et al., 1993; Chen et al., 1996;
Nicholas et al., 1996) and in NG108-15 cells expressing the
endogenous receptor (Lin et al., 1993); the strong activity of ITP
and relatively weak activity of UDP (see below) are particularly
noteworthy in this respect. The inhibitory activity of ADP was
less than that of UTP and appeared to be less than that of ATP,
but it was difﬁcult to quantitate because ADP produced some
inhibition of both M- and Ca
21 currents in control (GFP cRNA-
injected) cells (Fig. 7, shaded columns)—possibly via a low-
abundance endogenous P2Y1 receptor. ATP also partly inhibited
IK(M) in control cells; the other nucleotides tested (UTP, UDP,
ITP, GTP) did not produce any signiﬁcant effect on either Ca
21-
or M-current in the cells preinjected with GFP cRNA alone. [It
should be noted that, because the test concentration of UTP was
near-maximal, the relative heights of the bars in Fig. 7 do not
provide an accurate index of numerical potency ratios. For exam-
ple, ADP was ;50 times less potent than UTP in inhibiting ICa
when measured from full dose–response curves (Filippov et al.,
1997). Thus the dinucleotides ADP and UDP are likely to be at
least one or two orders of magnitude less potent than UTP in
inhibiting the M-current. Unfortunately, because of desensitiza-
Figure 4. Activation of heterologously expressed P2Y2 receptors inhibits
the M-type K
1 current (M-current; IK(M)) in rat SCG neurons. The
neuron was injected 18 hr beforehand with 1.25 mg/ml P2Y2 cRNA.
M-current was recorded with a perforated patch electrode by predepo-
larizing the neuron to 220 mV and then deactivating the current with 1
sec hyperpolarizing steps in increments of 10 mV at 5 sec intervals, as
shown in the current records. The graph shows the current amplitude at
the end of each 1 sec step measured as change from zero current. Currents
were recorded before ( ﬁlled squares; Control) and after ( ﬁlled circles) the
addition of 10 mM UTP. Note that UTP produced an inward current at the
holding potential of 220 mV, reduced the amplitude of the M-current
deactivation tail currents during the hyperpolarizing steps, and reduced
the outward rectiﬁcation of the current–voltage curve positive to 270 mV.
(The slight outward drift of the holding current in the presence of UTP
reﬂects slow receptor desensitization.)
Figure 3. PTX pretreatment eliminates
the voltage dependence of P2Y2-mediated
Ca
21 channel current inhibition. Cells
were pretreated with 500 ng/ml PTX.
Records in A show superimposed IBa traces
generated with the same double-pulse volt-
age protocol as in Figure 1D in the absence
and presence of 10 mM UTP. The bar
charts show the mean inhibition of IBa by 10
mM UTP before (Prep.0) and after
(Prep.120)a1120 mV prepulse in neurons
injected with 1.25 mg/ml P2Y2 cRNA (B)
and 0.5 mg/ml P2Y2 cRNA (C). Note that,
after PTX treatment, UTP no longer
slowed the recorded currents and that the
prepulse no longer signiﬁcantly reduced in-
hibition (compare with Fig. 1).
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dose–response curves for the inhibitory action of the weaker
analogs on the M-current.]
To check whether the effects of UDP and ADP in cRNA P2Y2
preinjected cells arise from possible contamination of these nu-
cleotides by UTP and ATP (see Nicholas et al., 1996), we per-
formed such tests by using puriﬁed UDP and ADP from Boehr-
inger Mannheim (99% pure) immediately after their dissolution
in the medium. In addition, we used samples of UDP and ADP
pretreated for 1 hr with hexokinase (1 mM UDP or ADP incu-
bated with 10 U/ml hexokinase plus 22 mM glucose at 37°C); this
should convert any UTP and ATP that was present to their
diphosphates (Nicholas et al., 1996). The hexokinase pretreat-
ment did not signiﬁcantly reduce the inhibitory effects of 10 mM
UDP or ADP, and the pure UDP and ADP produced inhibitions
within the range of those observed with the same nucleotides
from Sigma.
Effects on excitability
The inhibition of M-type K
1 currents and N-type Ca
21 currents
through endogenous G-protein-coupled receptors increases the
excitability of SCG neurons. This occurs because the M-current
itself acts as a “braking” current on action potential discharges
(see Brown, 1988), and the entry of Ca




1 channels and thereby induces
a long-lasting afterhyperpolarization (AHP), which further limits
subsequent spike activity [see Davies et al. (1996) and references
therein]. Thus, the activation of expressed P2Y2 receptors also
might be expected to enhance spike activity.
Figure 8 shows that this was the case. In Figure 8A, the cells
were challenged with long depolarizing or hyperpolarizing cur-
rent injections from a preset potential of 260 mV at room
temperature, at 20°C (Fig. 8Aa), and at 34°C (Fig. 8Ab). The long
depolarizing current induced a brief burst of two to three spikes,
followed by silence. The application of UTP had no effect on this
spike discharge in control cells preinjected with GFP cRNA but
greatly prolonged the discharge in cells preinjected with P2Y2
cRNA. This effect of UTP was increased dramatically at 34°C
(Fig. 8Ab); this occurs probably because M-current kinetics are
faster at 34°C (Brown, 1988), thereby exerting a faster and more
effective “brake” on ﬁring (see Cuevas et al., 1997). UTP also
increased the voltage response to hyperpolarizing current pulses
(Fig. 8Ab), as expected after M-current inhibition (see Adams et
al., 1982). These effects closely resemble the effect of activating
endogenous muscarinic receptors in SCG neurons (see Brown
and Constanti, 1980).
Figure 8B shows the effect of stimulating expressed P2Y2
receptors on the Ca
21-activated afterhyperpolarization that fol-
lows an action potential: UTP abbreviated the afterhyperpolar-
ization in a manner resembling the effect of stimulating endoge-
nous a2-adrenergic receptors with norepinephrine (Horn and
McAfee, 1980), which results from the inhibition of the N-type
Ca
21 current (Galvan and Adams, 1982; Schoﬁeld, 1990).
DISCUSSION
The principal points emerging from these and the preceding
experiments (Filippov et al., 1997) are that the recombinant rat
Figure 5. M-current inhibition by UTP requires heterologous P2Y2
receptor expression (A) and is not prevented by PTX (B). The bar chart
in A shows the mean percentage of inhibition of the M-current at 230 mV
(see Materials and Methods) by 10 mM UTP in neurons injected with 1.25
mg/ml P2Y2 cRNA (injected) and in uninjected neurons. Current inhibi-
tion by 10 mM oxotremorine-M (OxoM) in uninjected neurons is shown
for comparison. Error bars show SEM; n 5 number of cells tested.
The bar chart in B shows the mean percentage of inhibition of the
M-current by 10 mM UTP at 230 mV in neurons preinjected with P2Y2
cRNA without (Control)o rwi t h( 1PTX) overnight pretreatment with 0.5
mg/ml PTX.
Figure 6. Concentration dependence for UTP inhibition of M-current
(solid lines) and N-type Ca
21 channel current (dashed lines)i nc e l l s
preinjected with 1.25 mg/ml P2Y2 cRNA (circles)o r0 . 5mg/ml P2Y2 cRNA
(triangles). M-current was recorded by using a voltage ramp protocol
(inset) and was measured at 230 mV (see Materials and Methods). The
points show the mean 6 SEM of measurements in three to four cells;
concentrations were added cumulatively, with 1 min exposure times.
Curves were ﬁt to pooled data points, using Origin 4.1 software to the Hill
equation: y 5 ymax z x
nH/(x
nH 1 K
nH), where y 5 the observed percentage
of inhibition, ymax 5 extrapolated maximal percentage of inhibition, x 5
nucleotide concentration (mM), K 5 IC50 (mM), and nH 5 the Hill
coefﬁcient. Values of constants (mean 6 SEM) for M-current inhibition
were ymax 5 48.0 6 1.20%, K 5 1.49 6 0.14 mM, nH 5 1.29 6 0.14 for
neurons injected with 1.25 mg/ml P2Y2 cRNA; and ymax 5 43.2 6 1.95%,
K 5 2.41 6 0.43 mM, nH 5 0.88 6 0.11 for neurons injected with 0.5 mg/ml
P2Y2 cRNA. Data for Ca
21 channel current inhibition (dashed lines) are
taken from Filippov et al. (1997) and are superimposed for comparison.
(Values for constants were ymax 5 64.0 6 0.75%, K 5 0.50 6 0.03 mM, nH
5 1.29 6 0.0714 for neurons injected with 1.25 mg/ml P2Y2 cRNA; and
ymax 5 50.2 6 0.61%, K 5 0.90 6 0.05 mM, nH 5 1.21 6 0.06 for neurons
injected with 0.5 mg/ml P2Y2 cRNA).
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different neural ion channels—the N-type voltage-gated Ca
21
channel and the M-type K
1 channel—when expressed in rat SCG
neurons and that this involves the intermediation of at least two
different G-proteins. Dual coupling to these particular channels
by one species of G-protein-linked receptor is unusual (see be-
low) and suggests that the P2Y2 receptor can have a potentially
broader range of effects on neurons than many other neurotrans-
mitter receptors.
This apparent cross-talk is unlikely to be an artifact of receptor
overexpression, for two reasons. First, it was preserved after
injections of two different amounts of the receptor cRNA, such
that, at the lower level (0.5 mg/ml), the maximum response to
UTP was less than that obtained on stimulating endogenous
adrenergic and muscarinic receptors. Thus, although (in the ab-
sence of appropriate antibodies) we have not been able to mea-
sure the number of receptors expressed, they are unlikely to be
“excessive” in comparison to other endogenous serpentine recep-
tors in these cells. Second, the IC50 values for UTP observed in
the present experiments (0.5–0.9 mM for Ca
21 current inhibition
and 1.5–2.4 mM for M-current inhibition) are not dissimilar to
those observed for UTP to elevate intracellular [Ca
21] [1.1 mM,
Lustig et al. (1993); ;1.1 mM, Parr et al. (1994); 0.2 mM, Chen et
al. (1996)] or to stimulate inositol phosphate production (;0.1
mM; Nicholas et al., 1996) when applied to recombinant P2Y2
receptors expressed in other cell lines. (IC50 values likely will vary
from one expression system to another, depending on the level of
receptor expression, as indicated by the dose–response curves in
Fig. 6.) More pertinently, perhaps, the present IC50 values also
Figure 7. Mean effects of different nucleotides on M-current (A) and
Ca
21 channel current (B). Nucleotides were applied at 10 mM. Open bars
show the mean percentage of inhibition in neurons preinjected with 1.25
mg/ml P2Y2 cRNA; the shaded bars show the effects in control cells
(preinjected with GFP cRNA, but without P2Y2 cRNA). Error bars show
SEM; n 5 number of cells. Data for P2Y2 cRNA-injected cells in B were
recalculated from Filippov et al. (1997). Inhibition was measured as
described in Figures 2 and 6.
Figure 8. Activation of heterologously expressed P2Y2 receptors en-
hances repetitive ﬁring (A) and reduces the Ca
21-activated spike after-
hyperpolarization (B) in SCG neurons. Aa, Voltage responses to depo-
larizing current pulses (1 sec) recorded from a control (uninjected) SCG
neuron (top panel, 0.4 nA pulse) and from a P2Y2 cRNA (1.25 mg/ml)
preinjected neuron (middle panel, 0.1 nA pulse) before and during appli-
cation of UTP at 20°C. Ab, Voltage responses to depolarizing (0.3 nA)
and hyperpolarizing (20.2 nA) current pulses from P2Y2 cRNA (1.25
mg/ml) preinjected neuron before and during the application of UTP at
34°C. B, Afterhyperpolarization (AHP) that followed an action potential
evoked by a brief depolarizing current pulse (1 nA, 1 msec) recorded from
a P2Y2 cRNA (1.25 mg/ml) preinjected neuron before and during the
application of UTP at 34°C.
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P2Y2 receptor in NG108-15 cells [;3 mM for inositol phosphate
production (Lin, 1994); 0.8 mM for M-like current inhibition
(Filippov et al., 1994); 2.8 mM for N-type Ca
21 current inhibition
(Filippov and Brown, 1996)]. The agreement between the results
obtained on stimulating the endogenous receptors in this neural
cell line and the exogenously expressed receptors in SCG neurons
strongly suggests that the effects we see are likely to be a general
phenomenon, applicable in other cells in which the same receptor
might be expressed.
These divergent responses start at the level of the G-protein.
M-current inhibition was insensitive to PTX; although we have
not positively identiﬁed the species of PTX-resistant G-protein(s)
responsible, previous experiments that used site-directed anti-
bodies on the analogous effects of muscarinic agonists (Caulﬁeld
et al., 1994) and bradykinin (Jones et al., 1995) suggest that it is
most likely Gq and/or G11 (principally Gq; Haley et al., 1997). In
contrast, Ca
21 current inhibition is mediated by at least two
G-proteins: a PTX-sensitive G-protein, responsible for the gating
shift and for ;60% of the peak inhibition measured at 0 mV, and
a PTX-insensitive G-protein responsible for the residual voltage-
insensitive component of inhibition. By analogy with the voltage-
dependent effects of norepinephrine, somatostatin, and M4 mus-
carinic stimulation, the former (PTX-sensitive) G-protein is
probably GoA (Caulﬁeld et al., 1994; Delmas et al., 1998a,b), and
the gating shift probably results from the interaction of the
dissociated free bg-subunits with the Ca
21 channel protein (see
Herlitze et al., 1996; Ikeda, 1996; Delmas et al., 1998a,b). The
PTX-insensitive G-protein responsible for the voltage-insensitive
component of Ca
21 current inhibition could well be the same as
that (Gq?) postulated to cause M-current inhibition, because M1
muscarinic acetylcholine receptor stimulation produces the same
dual-effector response via Gq (Delmas et al., 1998b).
In effect, therefore, stimulating the P2Y2 receptor imitates the
combined effects of stimulating two separate endogenous musca-
rinic acetylcholine receptors, the M1 and the M4 receptors (see
Hille, 1994). This is summarized in Figure 9; at a minimum, it
requires parallel coupling of the P2Y2 receptor to two G-proteins:
Gq (leading to inhibition of the M-current and voltage-
independent inhibition of the Ca
21 current) and Go (producing a
gating shift of the Ca
21 channels).
There are other instances of “promiscuity” in receptor/G-
protein coupling (see Milligan, 1997). This can result in effects on
more than one ion channel—for example, the inhibition of Ca
21
currents and the activation of inward rectiﬁer (Kir)K
1 currents





M channels through two G-proteins by a single, deﬁned recep-
tor is more unusual. Thus, although many transmitters can, col-
lectively, modulate Ca
21 currents or M-currents in SCG neurons
in a manner similar to that produced by P2Y2 receptors (see Hille,
1994), this usually involves the activation of separate receptors,
each coupled to a different G-protein. As indicated already,
muscarinic acetylcholine agonists can produce the same dual
response as UTP, but to do so they have to activate two different
molecular species of muscarinic receptor; activation of Go (and
the Ca
21 channel gating shift) requires M4 receptors, whereas
activation of Gq (and consequential voltage-independent inhibi-
tion of M-current and Ca
21 current) requires M1 receptors (see
Beech et al., 1992; Delmas et al., 1998b). This also applies to
other heterologous receptors expressed by this method. Thus,
there is negligible cross-talk between heterologous mGluR1a and
mGluR2 receptors expressed from cRNA injections; the former
inhibit M-currents via a PTX-insensitive G-protein with insignif-
icant effect on the Ca
21 current, whereas mGluR2 receptors
inhibit Ca
21 currents entirely through a PTX-sensitive G-protein
without any effect on M-currents (Ikeda et al., 1995). Likewise,
heterologously expressed cannabinoid receptors selectively in-
hibit Ca
21 currents through a PTX-sensitive G-protein (Pan et
al., 1996). The closest analogy is provided by the action of
angiotensin, which also couples through two G-proteins (PTX-
sensitive and insensitive) to inhibit Ca
21 and M-currents (Sha-
piro et al., 1994); however, it has not yet been established whether
both coupling routes are activated by the same or different mo-
lecular species of angiotensin receptor.
Physiological signiﬁcance
From a functional viewpoint, the net effect of stimulating ex-
pressed P2Y2 receptors in SCG neurons is to increase their
excitability (see Fig. 8A). This is the expected result of inhibiting
the M-current and the N-type Ca
21 current, because reducing
the latter will decrease the Ca
21-dependent K
1 current and
abbreviate the spike afterhyperpolarization (as shown in Fig.
8B), and KM and KCa currents act as synergistic braking currents
on spike discharge (see Jones and Adams, 1987).
This is essentially a postsynaptic response; it mimics the natural
postsynaptic effect of activating the endogenous muscarinic re-
ceptors by synaptically released acetylcholine in SCG neurons
(see Brown, 1988), so it would provide a mechanism for slow
postsynaptic excitation by a nucleotide transmitter. Although no





M channels via two different G-proteins. Solid lines,
Direct connections; dashed lines, indirect connections.
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yet, comparable excitatory effects of exogenous UTP and ATP
have been described in, for example, frog sympathetic (Siggins et
al., 1977; Adams et al., 1982; Akasu et al., 1983; Lopez and
Adams, 1989), frog sensory (Tokimasa and Akasu, 1990), and rat
intracardiac (Cuevas et al., 1997) ganglion cells. However, the
species of P2Y receptor responsible for these effects has not been
determined, nor is there yet any direct evidence for equivalent
effects on central neurons.
On the other hand, if endogenous P2Y2 receptors were located
presynaptically, then the most likely effect of their stimulation
would be to reduce transmitter release via the inhibition of the
N-type Ca
21 current, in the same manner as stimulating endog-
enous presynaptic adrenergic or muscarinic receptors in SCG
neurons (Boehm and Huck, 1996; Koh and Hille, 1997). This
would provide a mechanism for autoinhibition in nucleotide-
releasing nerve terminals. There is some evidence for P2Y-
mediated autoinhibition in peripheral sympathetic nerves (Fuder
and Muth, 1993) and chromafﬁn cells (Currie and Fox, 1996);
also, P2Y-mediated inhibition of norepinephrine release from
isolated brain tissue by exogenous nucleotides has been reported
(Von Kugelgen et al., 1994), but the identity of these receptors
has not yet been established.
As pointed out in the introductory remarks, there is now direct
evidence for the synaptic release of ATP in the brain and the
consequent activation of postsynaptic P2X receptors (Edwards
and Gibb, 1993). Although there is, as yet, no evidence for the
synaptic release of UTP, the latter nucleotide can be released
from cells by other mechanisms (Lazarowski et al., 1997). Be-
cause mRNA for the P2Y2 receptor is expressed in the brain
(Lustig et al., 1993), were this receptor to be activated by either
of these endogenously released nucleotides, its dual coupling
would provide scope for some unusually divergent effects on
neural signaling.
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